GlassScriptPhysician profile
Jose Quilichini
NPI 1275646044
$2,363.55
in general payments reported to CMS, 2019-2025
11 companies · $341 in 2025
The $341 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $655 · 2020: $238 · 2021: $220 · 2022: $314 · 2023: $250 · 2024: $346 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,032.74 | 2019-2025 | Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $420.80 | 2022-2025 | Tagrisso |
| Abbott Laboratories | $251.58 | 2019-2025 | Portico |
| Medtronic, INC. | $242.62 | 2023-2024 | Invos, Symplicity G3 |
| Zimmer Biomet Holdings, INC. | $152.43 | 2019-2021 | |
| Terumo Cardiovascular Systems Corporation | $98.55 | 2025 | Virtuosaph Plus With Radial Indication |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.79 | 2022 | |
| Boston Scientific Corporation | $47.10 | 2024 | Greenlight Xps |
| Akcea Therapeutics, INC. | $33.06 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.58 | 2024 | Lifevest |
| Medtronic Vascular, INC. | $13.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Quilichini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.